SlideShare a Scribd company logo
 A female baby was born at 40 weeks of gestation and with
3200 g of birth weight had cyanosis and a heart murmur.
Echocardiogram revealed enlargement of the right ventricle,
large ventricular septal defect (8.4 mm), dextroposition of the
aorta (50%), and severe RVOT stenosis (PG 70 mm Hg) with
pulmonary hypoplasia. Pulmonary blood flow was secured
mainly by small ductus arteriosus. The patient started on
continuous prostaglandin infusion and was stabilised with
oxygen saturation approaching 80%.
 Early surgical repair
 Surgical shunts
 PDA stenting
 RVOT balloon dilatation
 RVOT stent
 Degree of cyanosis depends on
 degree of right ventricular outflow tract obstruction
 degree of pulmonary artery development
 Favorable anatomy – good size confluent PA’s – Total
correction
 In infancy and even in neonatal life, age is no BAR
Advantages of primary repair include
 early abolishment of cyanosis,
 minimisation of right ventricular hypertrophy and
fibrosis,
 avoidance of left ventricular volume-loading from
palliative shunts and
 potential reduction in dysrhythmias.
Major disadvantage : the neonatal brain may be more
prone to surgery-related neurological injury
Early primary repair : Preferred but not possible
when
 Unsuitable anatomy – small PAs
 Critically ill child
 Very small infant, LBW, Preterm
McGoon ratio: (Diameter of RPA + Diameter of LPA/DAo)
 Normal ≥ 2
 Adequate for primary repair 1.2
 Inadequate <0.8
Nakata Index: (CSA of RPA + CSA of LPA)/BSA
 Normal value > 200 mm2/m2
 > 150 mm2/m2 is adequate
 Not usable preoperatively when MAPCAs are the major source of PBF &
one-stage unifocalization + full repair is planned
 Surgical shunts
 PDA stenting
 RVOT balloon dilatation
 RVOT stent
 Neonatal shunt – high mortality and morbidity
 25- 30% neonatal mortality
Ann Card Anaesth 2014;17:191-7
 Overburdened surgical lists, Long stay (5-6 days post
surgery) and so bed occupancy in ICU!!
 Complication of CPB, Second surgery difficult, blockage in
not rare…
 PA growth and distortion of Pas.
CLSSICAL BT SHUNT
MODIFIED BT SHUNT
THE WATERSTON SHUNT
THE POTTS SHUNT
 Performed under general anaesthesia or deep
conscious sedation
 Preferable to have a mildly constricted duct (enough
to allow the stent to be secured)
 Recommended to stop prostaglandin infusion 6 - 12
hours before the procedure.
 To confirm ductal size - echocardiography before catheterisation
laboratory
 Delay the procedure if duct does not show a degree of constriction.
 If ductal diameter is large as a result of prostaglandin therapy it may
be of benefit to administer a prostaglandin inhibitor (ibuprofen 5 -
10mg/kg intravenously)
 Prefer to ensure good guide wire position before administering a
prostaglandin inhibitor as a protective measure
 Retrograde femoral arterial access is most commonly used
 Carotid and axillary routes have been described. The latter
requires cut down by a vascular surgeon
 Smaller sheath sizes preferred to avoid vascular
complications
 Patients heparinised (50 - 100U/kg iv) and routine
prophylactic antibiotics are given according to local
protocols
 Various catheters may be utilized for angiography and
stent.
 Routine angiography is usually performed with a pigtail
catheter
 In the majority of cases, the configuration of a right
coronary artery catheter should enable one to cross the
duct safely
 Sometimes a cut-off pigtail may be useful to cross the PDA.
 In difficult cases a coaxial system may be extremely helpful
 The following should be clearly demonstrated before stenting:
 Origin from the aortic arch,
 Diameter at pulmonary artery (most often the narrowest),
 Ampulla diameter and
 Ductal length
 Ductal length can be misleading as ducts are often convoluted
or angled, thus difficult to measure accurately.
 Measure the length of the PDA with the guide wire in position;
this tends to straighten the ductus and allows an improved
estimation of ductal length
 Standard bare metal coronary stents used
 Stents with the lowest profile are preferred
 It is of the utmost importance to stent the entire
length of the duct as any unstented segment
will soon become constricted and may be
extremely difficult to recannulate
 Stent sizes as recommended:
 3.5 mm diameter in those patients weighing <3kg
 4mm in those weighing 3 - 5kg, and
 4.5mm stents in those patients weighing 5kg and above.
 Heparin infusion is continued at a dose of 25U/kg/hr
for 24 - 48 hours.
 Aspirin is simultaneously initiated at 2 - 3mg/kg/day
and patients are discharged on this dose.
 Complicated duct anatomy
 Branch pulmonary artery stenosis
 Peri-procedural complications include
 Acute stent thrombosis (2 - 3%),
 Pre-stent ductal spasm (<1%),
 Stent dislodgement and migration,
 Vessel or chamber perforation
 Long term complications resemble those of surgical shunts
and consist of
 Progressive stent stenosis,
 Pulmonary overflow with pulmonary hypertension and
 Branch pulmonary artery distortion
 Reduced waiting period before intervention
 Avoids the side-effects of continuous prostaglandin
infusion
 Rapid post-procedure Recovery and short hospital stay
 Can be performed on relatively small and premature
newborns that are often critically ill.
 Adequate for valvular PS
 Inadequate for Infundibular or Supravalvular PS
 Most TOF pts  combined PS
 Unreliable results
 Small babies,
 With co morbidities,
 Small PAs ,
 Ostial stenosis of PAs,
 Need palliation, significant blue
RVOT stent
First described by Gibbs & Colleagues in 1997
Advantages of RVOT stenting –
 Physiological direction of pulsating flow
 Symmetric growth of MPA & both PAs
 Decreased morbidity as compared to surgical
shunt
FV – 5F - Small babies
6F – Can use guide catheter
RCA – BMW – Branch PA
Long sheath – useful – Injection – stent
 Diameter - on the pulmonary valve annulus – 1 – 2 mm
higher.
 Length - RVOT infundibular length
 Positioning equally important
 Consider preserving Pulmonary valve
 Peripheral Vascular stent
 BMS
 Express vascular stent
 Ballon expandable.
 ParaMount Mini GPS Balloon-Expandable - biliary
 Coronary stent – small babies.
 To preserved pulmonary valve
 If pulmonary valve not preserved, will needed  TAP;
 Most patient undergoing RVOT stenting, needed TAP
– usually small annulus
 Not to entrap the tricuspid valve with placement of the
stent
Take care to prevent stent embolization : too small
a stent  Inc risk of stent instability and
embolization
 Avoid entrapping Tricuspid valve
 Diuretics may be needed post stenting to prevent
reperfusion lung injury
 Case series and case reports from worldwide
 Not more than 200 cases reported
 RCT not possible,
 TC, PDA stenting and RVOT stenting had different
subjects.
 52 pts. Mean age – 63 days. Mean weight – 3.8 kg.
 Surgical intervention deemed high risk in all
 Only 1 procedural death and 1 emergency surgery
 Saturations increased from 71% (52-83%)  92% (81-100%)
Heart Online First, published on July 11, 2013 as 10.1136/heartjnl-2013-304155
Chesney D. Castleberry et al Pediatr Cardiol (2014) 35:423–430
Cardiol J 2008;15;376-9
ICR after RVOT stenting
D.J. Barron et al. / European Journal of Cardio-Thoracic Surgery 2013
 Most patient needed TAP – (Trans annular patch)
 RVOT stenting – very severe cyanosis – very tight PS –
small annulus – will also need patch in ICR.
 More bypass time and cross clamp time
 The average bypass time was 109 ± 42 min and cross-
clamp time 68 ± 29 min V/S 88 ± 36 min and 63 ± 22
min
Karl TR. Tetralogy of Fallot: current surgical perspective. Ann Pediatr Cardiol
2008;1:93–100
 Complete removal of the stent is not always possible.
 Often, remnants of the stent are embedded into the
myocardium and close to the VSD margins.
 Retained stent - focus for future ventricular
arrhythmias or infections ???
 The small retained portions of the stent- not prevent
satisfactory anatomical repair,  need close
surveillance in the future.
 RVOT stenting is a logical palliative procedure to augment
pulmonary blood flow
 It is feasible and generally safe
 Life saving in a critically ill patient who is unfit for surgical
palliation
 Small babies,
 With co morbidities,
 Small PAs ,
 Ostial stenosis of PAs,
 Need palliation, significant blue
RVOT stent
 Primary repair is treatment of choice whenever feasible
 Non surgical interventions such as PDA stenting, RVOT
stenting, and RVOT ballooning emerging as equally
effective and safe method of palliation as compared with
surgical shunts
Thank You

More Related Content

Similar to non surgical intervention in tof.pptx

Presentation on heart valve devices
Presentation on heart valve devicesPresentation on heart valve devices
Presentation on heart valve devices
BALASUBRAMANIAM IYER
 
TETRALOGY OF FALLOT
TETRALOGY OF FALLOTTETRALOGY OF FALLOT
TETRALOGY OF FALLOT
Indhu Reddy
 
Cardiac surgery and ptca
Cardiac surgery and ptcaCardiac surgery and ptca
Cardiac surgery and ptca
Qutaibah M. Oudat
 
Surgical management of tetralogy of fallot
Surgical management of tetralogy of fallotSurgical management of tetralogy of fallot
Surgical management of tetralogy of fallot
rahul arora
 
TransUlnar approach - our experience in nhf . Dr. Ashok Dutta
TransUlnar approach -  our experience in nhf . Dr. Ashok DuttaTransUlnar approach -  our experience in nhf . Dr. Ashok Dutta
TransUlnar approach - our experience in nhf . Dr. Ashok Dutta
Ashok Dutta
 
Coronary angioplasty : simplified
Coronary angioplasty  : simplifiedCoronary angioplasty  : simplified
Coronary angioplasty : simplified
Dr Jain T Kallarakkal
 
A case of prosthetic mitral valve with
A case of prosthetic mitral valve  withA case of prosthetic mitral valve  with
A case of prosthetic mitral valve with
Abhijeet Patil
 
Cyanotic chd
Cyanotic chdCyanotic chd
Cyanotic chd
Hristo Rahman
 
Pre op-assessment-of-the-surgical-patientsdfg
Pre op-assessment-of-the-surgical-patientsdfgPre op-assessment-of-the-surgical-patientsdfg
Pre op-assessment-of-the-surgical-patientsdfg
Fajar Salim
 
TAVI TEE.pdf
TAVI TEE.pdfTAVI TEE.pdf
TAVI TEE.pdf
MonaHamadto
 
Non surgical interventions
Non surgical interventionsNon surgical interventions
Non surgical interventionsgsquaresolution
 
DVR and ARE.pptx
DVR and ARE.pptxDVR and ARE.pptx
DVR and ARE.pptx
yassermubarak5
 
Pulmonary atresia with intact interventricular septum management
Pulmonary atresia with intact interventricular septum management Pulmonary atresia with intact interventricular septum management
Pulmonary atresia with intact interventricular septum management
Ramachandra Barik
 
CARDIOPULMONARY BYPASS AND PRETERM NEONATES
CARDIOPULMONARY BYPASS AND  PRETERM NEONATES CARDIOPULMONARY BYPASS AND  PRETERM NEONATES
CARDIOPULMONARY BYPASS AND PRETERM NEONATES
Adhi Arya
 
BALLOON AORTIC VALVULOPLASTY
BALLOON AORTIC VALVULOPLASTYBALLOON AORTIC VALVULOPLASTY
BALLOON AORTIC VALVULOPLASTY
Praveen Nagula
 
coronary perforation.pptx
coronary perforation.pptxcoronary perforation.pptx
coronary perforation.pptx
anuppusate1
 
The clincs coartacion de aorta y stents
The clincs   coartacion de aorta y stentsThe clincs   coartacion de aorta y stents
The clincs coartacion de aorta y stents
Diego Escobar
 
ptca rfa ppt.pptx, PTCA RFA, Percutaneous translu
ptca rfa ppt.pptx, PTCA RFA, Percutaneous transluptca rfa ppt.pptx, PTCA RFA, Percutaneous translu
ptca rfa ppt.pptx, PTCA RFA, Percutaneous translu
AnjuAnnMani1
 
Right heart catheterization
 Right heart catheterization Right heart catheterization
Right heart catheterization
Toufiqur Rahman
 

Similar to non surgical intervention in tof.pptx (20)

Presentation on heart valve devices
Presentation on heart valve devicesPresentation on heart valve devices
Presentation on heart valve devices
 
TETRALOGY OF FALLOT
TETRALOGY OF FALLOTTETRALOGY OF FALLOT
TETRALOGY OF FALLOT
 
Cardiac surgery and ptca
Cardiac surgery and ptcaCardiac surgery and ptca
Cardiac surgery and ptca
 
Surgical management of tetralogy of fallot
Surgical management of tetralogy of fallotSurgical management of tetralogy of fallot
Surgical management of tetralogy of fallot
 
TransUlnar approach - our experience in nhf . Dr. Ashok Dutta
TransUlnar approach -  our experience in nhf . Dr. Ashok DuttaTransUlnar approach -  our experience in nhf . Dr. Ashok Dutta
TransUlnar approach - our experience in nhf . Dr. Ashok Dutta
 
Coronary angioplasty : simplified
Coronary angioplasty  : simplifiedCoronary angioplasty  : simplified
Coronary angioplasty : simplified
 
A case of prosthetic mitral valve with
A case of prosthetic mitral valve  withA case of prosthetic mitral valve  with
A case of prosthetic mitral valve with
 
Cyanotic chd
Cyanotic chdCyanotic chd
Cyanotic chd
 
Pre op-assessment-of-the-surgical-patientsdfg
Pre op-assessment-of-the-surgical-patientsdfgPre op-assessment-of-the-surgical-patientsdfg
Pre op-assessment-of-the-surgical-patientsdfg
 
TAVI TEE.pdf
TAVI TEE.pdfTAVI TEE.pdf
TAVI TEE.pdf
 
Non surgical interventions
Non surgical interventionsNon surgical interventions
Non surgical interventions
 
DVR and ARE.pptx
DVR and ARE.pptxDVR and ARE.pptx
DVR and ARE.pptx
 
Pulmonary atresia with intact interventricular septum management
Pulmonary atresia with intact interventricular septum management Pulmonary atresia with intact interventricular septum management
Pulmonary atresia with intact interventricular septum management
 
CARDIOPULMONARY BYPASS AND PRETERM NEONATES
CARDIOPULMONARY BYPASS AND  PRETERM NEONATES CARDIOPULMONARY BYPASS AND  PRETERM NEONATES
CARDIOPULMONARY BYPASS AND PRETERM NEONATES
 
BALLOON AORTIC VALVULOPLASTY
BALLOON AORTIC VALVULOPLASTYBALLOON AORTIC VALVULOPLASTY
BALLOON AORTIC VALVULOPLASTY
 
coronary perforation.pptx
coronary perforation.pptxcoronary perforation.pptx
coronary perforation.pptx
 
The clincs coartacion de aorta y stents
The clincs   coartacion de aorta y stentsThe clincs   coartacion de aorta y stents
The clincs coartacion de aorta y stents
 
ptca rfa ppt.pptx, PTCA RFA, Percutaneous translu
ptca rfa ppt.pptx, PTCA RFA, Percutaneous transluptca rfa ppt.pptx, PTCA RFA, Percutaneous translu
ptca rfa ppt.pptx, PTCA RFA, Percutaneous translu
 
A T L S
A T L SA T L S
A T L S
 
Right heart catheterization
 Right heart catheterization Right heart catheterization
Right heart catheterization
 

More from Shivani Rao

ECG DIAGNOSIS OF ACUTE CORONARY SYNDROME.pptx
ECG DIAGNOSIS OF ACUTE CORONARY SYNDROME.pptxECG DIAGNOSIS OF ACUTE CORONARY SYNDROME.pptx
ECG DIAGNOSIS OF ACUTE CORONARY SYNDROME.pptx
Shivani Rao
 
approach to stemi in non pci centre.pptx
approach to stemi in non pci centre.pptxapproach to stemi in non pci centre.pptx
approach to stemi in non pci centre.pptx
Shivani Rao
 
NATURAL HISTORY, HEMODYNAMICS AND SURGICAL MANAGEMENT OF AORTIC STENOSIS.pptx
NATURAL HISTORY, HEMODYNAMICS AND SURGICAL MANAGEMENT  OF AORTIC STENOSIS.pptxNATURAL HISTORY, HEMODYNAMICS AND SURGICAL MANAGEMENT  OF AORTIC STENOSIS.pptx
NATURAL HISTORY, HEMODYNAMICS AND SURGICAL MANAGEMENT OF AORTIC STENOSIS.pptx
Shivani Rao
 
Cardiac Embryology basics.pptx
Cardiac Embryology basics.pptxCardiac Embryology basics.pptx
Cardiac Embryology basics.pptx
Shivani Rao
 
emergency echo in critically ill patients.ppt
emergency echo in critically ill patients.pptemergency echo in critically ill patients.ppt
emergency echo in critically ill patients.ppt
Shivani Rao
 
Fontan circulation
Fontan circulationFontan circulation
Fontan circulation
Shivani Rao
 
reversible cardiomyopathies
reversible cardiomyopathiesreversible cardiomyopathies
reversible cardiomyopathies
Shivani Rao
 
TREADMILL TESTING
TREADMILL TESTINGTREADMILL TESTING
TREADMILL TESTING
Shivani Rao
 
cardiac ion channels and channelopathies
cardiac ion channels and channelopathiescardiac ion channels and channelopathies
cardiac ion channels and channelopathies
Shivani Rao
 
Surgery vs conservative strategy in aortic stenosis
Surgery vs conservative strategy in aortic stenosisSurgery vs conservative strategy in aortic stenosis
Surgery vs conservative strategy in aortic stenosis
Shivani Rao
 
PCKS9 INHIBITORS
PCKS9 INHIBITORSPCKS9 INHIBITORS
PCKS9 INHIBITORS
Shivani Rao
 
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MIFFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
Shivani Rao
 

More from Shivani Rao (12)

ECG DIAGNOSIS OF ACUTE CORONARY SYNDROME.pptx
ECG DIAGNOSIS OF ACUTE CORONARY SYNDROME.pptxECG DIAGNOSIS OF ACUTE CORONARY SYNDROME.pptx
ECG DIAGNOSIS OF ACUTE CORONARY SYNDROME.pptx
 
approach to stemi in non pci centre.pptx
approach to stemi in non pci centre.pptxapproach to stemi in non pci centre.pptx
approach to stemi in non pci centre.pptx
 
NATURAL HISTORY, HEMODYNAMICS AND SURGICAL MANAGEMENT OF AORTIC STENOSIS.pptx
NATURAL HISTORY, HEMODYNAMICS AND SURGICAL MANAGEMENT  OF AORTIC STENOSIS.pptxNATURAL HISTORY, HEMODYNAMICS AND SURGICAL MANAGEMENT  OF AORTIC STENOSIS.pptx
NATURAL HISTORY, HEMODYNAMICS AND SURGICAL MANAGEMENT OF AORTIC STENOSIS.pptx
 
Cardiac Embryology basics.pptx
Cardiac Embryology basics.pptxCardiac Embryology basics.pptx
Cardiac Embryology basics.pptx
 
emergency echo in critically ill patients.ppt
emergency echo in critically ill patients.pptemergency echo in critically ill patients.ppt
emergency echo in critically ill patients.ppt
 
Fontan circulation
Fontan circulationFontan circulation
Fontan circulation
 
reversible cardiomyopathies
reversible cardiomyopathiesreversible cardiomyopathies
reversible cardiomyopathies
 
TREADMILL TESTING
TREADMILL TESTINGTREADMILL TESTING
TREADMILL TESTING
 
cardiac ion channels and channelopathies
cardiac ion channels and channelopathiescardiac ion channels and channelopathies
cardiac ion channels and channelopathies
 
Surgery vs conservative strategy in aortic stenosis
Surgery vs conservative strategy in aortic stenosisSurgery vs conservative strategy in aortic stenosis
Surgery vs conservative strategy in aortic stenosis
 
PCKS9 INHIBITORS
PCKS9 INHIBITORSPCKS9 INHIBITORS
PCKS9 INHIBITORS
 
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MIFFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
FFR GUIDED MULTIVESSEL ANGIOPLASTY IN MI
 

Recently uploaded

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 

Recently uploaded (20)

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 

non surgical intervention in tof.pptx

  • 1.
  • 2.  A female baby was born at 40 weeks of gestation and with 3200 g of birth weight had cyanosis and a heart murmur. Echocardiogram revealed enlargement of the right ventricle, large ventricular septal defect (8.4 mm), dextroposition of the aorta (50%), and severe RVOT stenosis (PG 70 mm Hg) with pulmonary hypoplasia. Pulmonary blood flow was secured mainly by small ductus arteriosus. The patient started on continuous prostaglandin infusion and was stabilised with oxygen saturation approaching 80%.
  • 3.  Early surgical repair  Surgical shunts  PDA stenting  RVOT balloon dilatation  RVOT stent
  • 4.  Degree of cyanosis depends on  degree of right ventricular outflow tract obstruction  degree of pulmonary artery development  Favorable anatomy – good size confluent PA’s – Total correction  In infancy and even in neonatal life, age is no BAR
  • 5. Advantages of primary repair include  early abolishment of cyanosis,  minimisation of right ventricular hypertrophy and fibrosis,  avoidance of left ventricular volume-loading from palliative shunts and  potential reduction in dysrhythmias. Major disadvantage : the neonatal brain may be more prone to surgery-related neurological injury
  • 6. Early primary repair : Preferred but not possible when  Unsuitable anatomy – small PAs  Critically ill child  Very small infant, LBW, Preterm
  • 7. McGoon ratio: (Diameter of RPA + Diameter of LPA/DAo)  Normal ≥ 2  Adequate for primary repair 1.2  Inadequate <0.8 Nakata Index: (CSA of RPA + CSA of LPA)/BSA  Normal value > 200 mm2/m2  > 150 mm2/m2 is adequate  Not usable preoperatively when MAPCAs are the major source of PBF & one-stage unifocalization + full repair is planned
  • 8.  Surgical shunts  PDA stenting  RVOT balloon dilatation  RVOT stent
  • 9.  Neonatal shunt – high mortality and morbidity  25- 30% neonatal mortality Ann Card Anaesth 2014;17:191-7  Overburdened surgical lists, Long stay (5-6 days post surgery) and so bed occupancy in ICU!!  Complication of CPB, Second surgery difficult, blockage in not rare…  PA growth and distortion of Pas.
  • 10. CLSSICAL BT SHUNT MODIFIED BT SHUNT THE WATERSTON SHUNT THE POTTS SHUNT
  • 11.
  • 12.  Performed under general anaesthesia or deep conscious sedation  Preferable to have a mildly constricted duct (enough to allow the stent to be secured)  Recommended to stop prostaglandin infusion 6 - 12 hours before the procedure.
  • 13.  To confirm ductal size - echocardiography before catheterisation laboratory  Delay the procedure if duct does not show a degree of constriction.  If ductal diameter is large as a result of prostaglandin therapy it may be of benefit to administer a prostaglandin inhibitor (ibuprofen 5 - 10mg/kg intravenously)  Prefer to ensure good guide wire position before administering a prostaglandin inhibitor as a protective measure
  • 14.  Retrograde femoral arterial access is most commonly used  Carotid and axillary routes have been described. The latter requires cut down by a vascular surgeon  Smaller sheath sizes preferred to avoid vascular complications  Patients heparinised (50 - 100U/kg iv) and routine prophylactic antibiotics are given according to local protocols
  • 15.  Various catheters may be utilized for angiography and stent.  Routine angiography is usually performed with a pigtail catheter  In the majority of cases, the configuration of a right coronary artery catheter should enable one to cross the duct safely  Sometimes a cut-off pigtail may be useful to cross the PDA.  In difficult cases a coaxial system may be extremely helpful
  • 16.  The following should be clearly demonstrated before stenting:  Origin from the aortic arch,  Diameter at pulmonary artery (most often the narrowest),  Ampulla diameter and  Ductal length  Ductal length can be misleading as ducts are often convoluted or angled, thus difficult to measure accurately.  Measure the length of the PDA with the guide wire in position; this tends to straighten the ductus and allows an improved estimation of ductal length
  • 17.  Standard bare metal coronary stents used  Stents with the lowest profile are preferred  It is of the utmost importance to stent the entire length of the duct as any unstented segment will soon become constricted and may be extremely difficult to recannulate
  • 18.  Stent sizes as recommended:  3.5 mm diameter in those patients weighing <3kg  4mm in those weighing 3 - 5kg, and  4.5mm stents in those patients weighing 5kg and above.  Heparin infusion is continued at a dose of 25U/kg/hr for 24 - 48 hours.  Aspirin is simultaneously initiated at 2 - 3mg/kg/day and patients are discharged on this dose.
  • 19.
  • 20.
  • 21.
  • 22.  Complicated duct anatomy  Branch pulmonary artery stenosis
  • 23.  Peri-procedural complications include  Acute stent thrombosis (2 - 3%),  Pre-stent ductal spasm (<1%),  Stent dislodgement and migration,  Vessel or chamber perforation  Long term complications resemble those of surgical shunts and consist of  Progressive stent stenosis,  Pulmonary overflow with pulmonary hypertension and  Branch pulmonary artery distortion
  • 24.  Reduced waiting period before intervention  Avoids the side-effects of continuous prostaglandin infusion  Rapid post-procedure Recovery and short hospital stay  Can be performed on relatively small and premature newborns that are often critically ill.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.  Adequate for valvular PS  Inadequate for Infundibular or Supravalvular PS  Most TOF pts  combined PS  Unreliable results
  • 32.
  • 33.  Small babies,  With co morbidities,  Small PAs ,  Ostial stenosis of PAs,  Need palliation, significant blue RVOT stent
  • 34. First described by Gibbs & Colleagues in 1997 Advantages of RVOT stenting –  Physiological direction of pulsating flow  Symmetric growth of MPA & both PAs  Decreased morbidity as compared to surgical shunt
  • 35. FV – 5F - Small babies 6F – Can use guide catheter RCA – BMW – Branch PA Long sheath – useful – Injection – stent
  • 36.
  • 37.  Diameter - on the pulmonary valve annulus – 1 – 2 mm higher.  Length - RVOT infundibular length  Positioning equally important  Consider preserving Pulmonary valve
  • 38.  Peripheral Vascular stent  BMS  Express vascular stent  Ballon expandable.  ParaMount Mini GPS Balloon-Expandable - biliary  Coronary stent – small babies.
  • 39.  To preserved pulmonary valve  If pulmonary valve not preserved, will needed  TAP;  Most patient undergoing RVOT stenting, needed TAP – usually small annulus  Not to entrap the tricuspid valve with placement of the stent
  • 40. Take care to prevent stent embolization : too small a stent  Inc risk of stent instability and embolization  Avoid entrapping Tricuspid valve  Diuretics may be needed post stenting to prevent reperfusion lung injury
  • 41.
  • 42.
  • 43.
  • 44.  Case series and case reports from worldwide  Not more than 200 cases reported  RCT not possible,  TC, PDA stenting and RVOT stenting had different subjects.
  • 45.  52 pts. Mean age – 63 days. Mean weight – 3.8 kg.  Surgical intervention deemed high risk in all  Only 1 procedural death and 1 emergency surgery  Saturations increased from 71% (52-83%)  92% (81-100%) Heart Online First, published on July 11, 2013 as 10.1136/heartjnl-2013-304155
  • 46. Chesney D. Castleberry et al Pediatr Cardiol (2014) 35:423–430
  • 48.
  • 49.
  • 50.
  • 51.
  • 52. ICR after RVOT stenting
  • 53. D.J. Barron et al. / European Journal of Cardio-Thoracic Surgery 2013
  • 54.  Most patient needed TAP – (Trans annular patch)  RVOT stenting – very severe cyanosis – very tight PS – small annulus – will also need patch in ICR.  More bypass time and cross clamp time  The average bypass time was 109 ± 42 min and cross- clamp time 68 ± 29 min V/S 88 ± 36 min and 63 ± 22 min Karl TR. Tetralogy of Fallot: current surgical perspective. Ann Pediatr Cardiol 2008;1:93–100
  • 55.  Complete removal of the stent is not always possible.  Often, remnants of the stent are embedded into the myocardium and close to the VSD margins.  Retained stent - focus for future ventricular arrhythmias or infections ???  The small retained portions of the stent- not prevent satisfactory anatomical repair,  need close surveillance in the future.
  • 56.  RVOT stenting is a logical palliative procedure to augment pulmonary blood flow  It is feasible and generally safe  Life saving in a critically ill patient who is unfit for surgical palliation
  • 57.  Small babies,  With co morbidities,  Small PAs ,  Ostial stenosis of PAs,  Need palliation, significant blue RVOT stent
  • 58.  Primary repair is treatment of choice whenever feasible  Non surgical interventions such as PDA stenting, RVOT stenting, and RVOT ballooning emerging as equally effective and safe method of palliation as compared with surgical shunts

Editor's Notes

  1. Right ventricular (RV) angiography in the right anterior oblique view shows the aorta (Ao) and the RV outflow tract, which is severely stenotic due to anterosuperior deviation of the infundibular septum and pulmonary valve dysplasia (arrow). Note that the left pulmonary artery (LPA) is not visible. B) Ascending aortography in the posteroanterior view before stent deployment shows the origin of the LPA from a left-sided patent ductus arteriosus, with moderate stenosis at the PDA–LPA junction (arrow). The asterisk (*) indicates the crista supraventricularis; RPA = right pulmonary artery
  2. The stent positioning inside the patent ductus arteriosus is angiographically guided through the 4F introducer sheath, without the need for a guiding catheter. The asterisk (*) indicates the pre-mounted coronary artery stent; Ao = aorta
  3. The final angiographic result is shown after the patent ductus arteriosus stenting. Note that the stent is slightly oversized. B) Angiogram shows the appearance of the stented patient ductus arteriosus 6 months after implantation. There was a moderate aortic–LPA pressure gradient (aortic pressure, 60/22 mmHg; LPA pressure, 25/10 mmHg). The asterisk (*) and the arrow both indicate the stented patent ductus arteriosus; Ao = aorta; LPA = left pulmonary artery